Targeting TRPV1 for Cancer Pain Relief: Can It Work?
1Department of Pathology and Experimental Cancer Research, Semmelweis University, 1085 Budapest, Hungary.
Cancers
|February 10, 2024
Summary
Blocking cancer pain with TRPV1 agonists offers an opioid-sparing alternative. However, TRPV1 blockade may impact cancer progression differently depending on the cancer type, requiring careful consideration for pain management.
Area of Science:
- Pain management
- Oncology
- Neuroscience
Background:
- Chronic intractable pain is prevalent in cancer patients, particularly with bone metastases.
- Current treatments like opioids have limitations, including addiction and CNS side effects.
- Sensory nerve blockers targeting the capsaicin receptor TRPV1 offer a non-addictive alternative.
Purpose of the Study:
- To review the analgesic potential of TRPV1 agonists for cancer pain.
- To explore the impact of TRPV1 blockade on cancer progression.
- To compare TRPV1 antagonism and sensory afferent desensitization for cancer pain relief.
Main Methods:
- Review of existing literature on TRPV1 agonists (capsaicin, resiniferatoxin) in cancer pain.
- Analysis of studies investigating TRPV1-mediated effects on cancer progression in preclinical models.
- Comparison of analgesic efficacy and potential contraindications.
Main Results:
- Intrathecal resiniferatoxin provides permanent analgesia for bone metastasis pain by ablating TRPV1 nerve endings.
- High-dose capsaicin patches effectively treat chemotherapy-induced neuropathic pain.
- TRPV1 blockade's effect on cancer progression varies; capsaicin accelerated breast cancer, while resiniferatoxin inhibited melanoma growth.
Conclusions:
- TRPV1 agonists show promise for cancer pain relief, offering an alternative to opioids.
- The impact of TRPV1 blockade on cancer progression is complex and cancer-specific.
- Further research is needed to determine optimal TRPV1-targeted therapies for different cancer types.
Related Concept Videos
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
163
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
163
01:21Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
278
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
278
01:25Analgesia and Pain Management
623
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
623
01:30Cancer Vaccines
367
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
367
01:27Tumor Immunotherapy
524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
01:43Thermosensation
30.4K
Peripheral thermosensation is the perception of external temperature. A change in temperature (on the surface of the skin and other tissues) is detected by a family of temperature-sensitive ion channels called Transient Receptor Potential, or TRP, receptors. These receptors are located on free nerve endings. Those detecting cold temperatures are closer to the surface of the skin than the nerve endings detecting warmth. These thermoTRP channels, while temperature selective, have relatively...
30.4K